Conversely, DNMT1-mediated methylation silences chemokines such as CXCL9 and CXCL10, leading to reduced anti-tumor immune cell infiltration; the restoration of TET1 and TET2 can reverse this effect and improve the efficacy of immune checkpoint inhibitors (ICIs) (149). Here, CXCL10 is linked to neoplasm.